Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 Q1- Text added to 2021 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
abstract, American, ASCO, baseline, biotherapeutic, built, burden, CDMO, central, compromised, diarrhea, Durham, effort, eliciting, entitled, escalation, event, fatigue, fifteen, fight, franchise, gaining, glycoprotein, half, haplotype, hazard, HR, incompetent, injection, ISR, journal, KTP, led, longer, maculopapular, megabase, mOS, mutation, mutational, NaN, nausea, onsite, poster, pts, quickly, rash, ratio, reaction, remission, replication, ROU, Society, subset, suited, surveillance, tabular, Tech, tenant, trend, undiscounted, unregistered, vivarium
Valuein 2021 Q1 filing- Value in 2021 Q2 filing
Original filings
Filing view